Literature DB >> 11020850

Results of resection for hilar cholangiocarcinoma with analysis of prognostic factors.

R Havlik1, E Sbisà, A Tullo, M D Kelly, R R Mitry, L R Jiao, M R Mansour, K Honda, N A Habib.   

Abstract

BACKGROUND/AIMS: Resection for hilar cholangiocarcinoma remains a challenging procedure and recent published results continue to show that few patients are cured of their disease. The objective of this review was to determine the results of radical resection and to identify factors associated with long-term survival.
METHODOLOGY: Retrospective review of resection for hilar cholangiocarcinoma in 29 consecutive patients with statistical analysis of prognostic factors, including p53 status.
RESULTS: The mortality and morbidity rates were 6.9% and 34%, respectively. The overall 5-year survival was 20% with the median survival being 16 months. Univariate analysis identified the following factors associated with poor survival; involved lymph nodes, vascular invasion, advanced tumor stage, positive tumor margins, and p53 mutation. However, none of these factors was associated with poor survival by multivariate analyses.
CONCLUSIONS: Radical resection for hilar cholangiocarcinoma can be performed with acceptable morbidity and mortality, but most patients succumb to their disease. p53 status may be a helpful adjunct to routine pathological staging.

Entities:  

Mesh:

Year:  2000        PMID: 11020850

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  14 in total

1.  NCCN clinical practice guidelines in oncology: hepatobiliary cancers.

Authors:  Al B Benson; Thomas A Abrams; Edgar Ben-Josef; P Mark Bloomston; Jean F Botha; Bryan M Clary; Anne Covey; Steven A Curley; Michael I D'Angelica; Rene Davila; William D Ensminger; John F Gibbs; Daniel Laheru; Mokenge P Malafa; Jorge Marrero; Steven G Meranze; Sean J Mulvihill; James O Park; James A Posey; Jasgit Sachdev; Riad Salem; Elin R Sigurdson; Constantinos Sofocleous; Jean-Nicolas Vauthey; Alan P Venook; Laura Williams Goff; Yun Yen; Andrew X Zhu
Journal:  J Natl Compr Canc Netw       Date:  2009-04       Impact factor: 11.908

2.  Prognostic factors in patients with advanced cholangiocarcinoma: role of surgery, chemotherapy and body mass index.

Authors:  Mirna H Farhat; Ali I Shamseddine; Ayman N Tawil; Ghina Berjawi; Charif Sidani; Wael Shamseddeen; Kassem A Barada
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

3.  Photodynamic therapy: Palliation and endoscopic technique in cholangiocarcinoma.

Authors:  James A Richter; Michel Kahaleh
Journal:  World J Gastrointest Endosc       Date:  2010-11-16

Review 4.  Cholangiocarcinoma: modern advances in understanding a deadly old disease.

Authors:  Harmeet Malhi; Gregory J Gores
Journal:  J Hepatol       Date:  2006-09-25       Impact factor: 25.083

5.  Multivariate statistical analysis of clinicopathologic factors influencing survival of patients with bile duct carcinoma.

Authors:  Ping He; Jin-Sen Shi; Wu-Ke Chen; Zuo-Ren Wang; Hong Ren; Hua Li
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

6.  Photodynamic therapy for cholangiocarcinoma.

Authors:  Jayant P Talreja; Michel Kahaleh
Journal:  Gut Liver       Date:  2010-09-10       Impact factor: 4.519

7.  Long-term survival after intraluminal brachytherapy for inoperable hilar cholangiocarcinoma: a case report.

Authors:  Siu-Yin Chan; Ronnie T Poon; Kelvin K Ng; Chi-Leung Liu; Raymond T Chan; Sheung-Tat Fan
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

8.  Improved survival following right trisectionectomy with caudate lobectomy without operative mortality: surgical treatment for hilar cholangiocarcinoma.

Authors:  Kwang Yeol Paik; Dong Wook Choi; Jun Chul Chung; Kyung Tae Kang; Sang Bum Kim
Journal:  J Gastrointest Surg       Date:  2008-03-11       Impact factor: 3.452

9.  Outcome of surgical resection in Klatskin tumors.

Authors:  Alejandro Serrablo; Luis Tejedor
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

10.  Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study.

Authors:  Satoshi Kondo; Satoshi Hirano; Yoshiyasu Ambo; Eiichi Tanaka; Shunichi Okushiba; Toshiaki Morikawa; Hiroyuki Katoh
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.